You can buy or sell iRhythm and other stocks, options, ETFs, and crypto commission-free!
iRhythm Technologies, Inc. Common Stock, also called iRhythm, is a commercial-stage digital healthcare company, which engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. Read More It offers ZIO which diagnose many arrhythmias, avoiding multiple indeterminate tests, allowing for appropriate medical intervention, and prevents serious downstream medical events. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.
San Francisco, California
52 Week High
52 Week Low
Yahoo FinanceMay 8
iRhythm Technologies Announces Investor Update Webcast on May 9, 2019
SAN FRANCISCO, May 08, 2019 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (IRTC), a leading digital health company focused on the advancement of cardiac care, announced today that it will host an analyst and institutional investor update webcast on Thursday, May 9, 2019 from 7:00 a.m. to approximately 8:30 a.m. Pacific Time to coincide with the 40th Annual Heart Rhythm Scientific Sessions. The webcast will include remarks from members of the iRhythm Technologies leadership team on its platform for growt...
The Motley FoolMay 8
iRhythm Technologies, Inc. Common Stock (IRTC) Q1 2019 Earnings Call Transcript
iRhythm Technologies, Inc. Common Stock (NASDAQ:IRTC) Q1 2019 Earnings Call , 4:30 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good afternoon, ladies and gentlemen, and welcome to the iRhythm Technologies, Inc. Q1 2019 earnings conference call. [Operator instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Ms. Lynn Lewis with investor relations. Please go ahead. Lynn Lew...
Associated PressMay 7
iRhythm Technologies Announces First Quarter 2019 Financial Results
SAN FRANCISCO, May 07, 2019 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended March 31, 2019. First Quarter 2019 Highlights -- Revenue of $47.2 million for the three months ended March 31, 2019 • 54% increase compared to first quarter revenue reported in 2018 • 9% sequential growth versus fourth quarter 2018 -- Gross margin was 75.2% • 340 bas...
Expected Jul 31, After Hours